Saba Capital Management, L.P. has made a notable move by increasing its stake in Ellsworth Growth & Income Fund Ltd. The investment management firm reported acquiring 11,565 shares on October 30, 2026, bringing its total holdings in Ellsworth to 1,814,063 shares. This acquisition emphasizes Saba's ongoing commitment to its investment strategy and may have implications for the broader investment management industry.
Background
Saba Capital Management, L.P. is a Delaware-based investment management firm. It specializes in managing funds and accounts, primarily focusing on equity investments. The firm operates under the Central Index Key (CIK) number 0001510281. Recent filings show that Saba has been actively managing its investments, with multiple Form 4 submissions made in late October 2026.
What the Filing Says
According to the recent filing (accession number 0001510281-26-000401), Saba Capital acquired 11,565 shares of Ellsworth Growth & Income Fund Ltd at a price of $11.77 per share. The filing states, "The securities reported herein are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager." This indicates that Saba is managing these securities on behalf of its clients.
Impact
This acquisition could affect various stakeholders, including investors in both Saba Capital and Ellsworth Growth & Income Fund Ltd. As Saba increases its ownership, it may influence the strategic direction of Ellsworth, as well as impact other investment firms in the sector. The move highlights Saba's active role in managing its investments and could prompt other firms to reassess their strategies.
What's Next
The filing does not say what happens next regarding Saba's investment strategy or any potential future acquisitions.
Read Next
Smith Byron Jr. Acquires 1,160 Shares of Northern Trust Corp
Etsy CFO Charles Baker Reports Stock Transactions
Catalyst Acquisition Corp. Updates Beneficial Ownership Stakes
Hampton Financial Corp Raises Governance Concerns Over Icon Energy
HCA Healthcare Executive Reports Multiple Stock Transactions
LENZ Therapeutics updates beneficial ownership in SEC filing








